Affiliation:
1. Departments of Surgery and Biostatistic, University of Liverpool
Abstract
Abstract
Colorectal liver metastases develop by malignant cells entering the portal venous circulation. A randomized prospective clinical trial was commenced in 1975 to assess the value of adjuvant umbilical vein cytotoxic perfusion (with 5-fluorouracil) following colorectal resection.
One hundred and fifty-four patients without macroscopic liver secondaries have so far entered the trial. The mean age, sex, site and stage of the disease were similar in the control and perfusion groups and there was no statistically significant difference in postoperative complications or hospital stay (17·1 ± 7·9 days control, 15·8 ± 7·4 days perfusion group).
So far, 23 deaths have occurred in the control group (20 due to recurrent disease) and 7 in the perfusion. group (5 due to recurrent disease) Liver metastases were present in 13 control patients and 2 perfusion patients.
These results show an encouraging trend and suggest that adjuvant cytotoxic liver perfusion may reduce the development of colorectal liver metastases and hence improve the subsequent prognosis.
Publisher
Oxford University Press (OUP)
Reference29 articles.
1. The natural history of primary and secondary malignant tumours of the liver. 1. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy;Bengmark;Cancer,1969
2. Visceral metastases from rectal carcinoma;Brown;Surg. Gynecol. Obstet.,1938
3. Role of operative stress on the resistance of the experimental animal to inoculated cancer cells;Buinauskas;Ann. Surg.,1958
4. The value of liver scan in the follow-up study of patients with adenocarcinoma of the colon and rectum;Cedermark;Surg. Gynecol. Obstet.,1977
5. Prophylactic treatment of cancer;Cruz;Surgery,1956
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献